🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/08/2003 | 51,91 | 53,48 | 51,77 | 53,34 | +3,10% | 3,29% | 8.407.266 |
| 06/08/2003 | 51,06 | 52,22 | 50,76 | 51,74 | +1,33% | 2,86% | 5.992.778 |
| 05/08/2003 | 51,72 | 52,28 | 50,95 | 51,06 | -1,15% | 2,56% | 7.614.034 |
| 04/08/2003 | 51,62 | 51,86 | 50,81 | 51,65 | -0,17% | 2,03% | 6.805.188 |
| 01/08/2003 | 52,49 | 52,57 | 51,05 | 51,74 | -1,92% | 2,89% | 7.591.607 |
| 31/07/2003 | 53,29 | 54,01 | 52,51 | 52,75 | -0,32% | 2,81% | 7.254.885 |
| 30/07/2003 | 53,02 | 53,63 | 52,64 | 52,92 | +0,13% | 1,85% | 6.722.396 |
| 29/07/2003 | 54,37 | 54,49 | 52,58 | 52,85 | -2,24% | 3,53% | 13.749.865 |
| 28/07/2003 | 54,85 | 54,87 | 53,67 | 54,06 | -1,50% | 2,17% | 6.385.254 |
| 25/07/2003 | 54,06 | 54,89 | 53,66 | 54,89 | +0,93% | 2,26% | 5.776.157 |
| 24/07/2003 | 55,53 | 55,56 | 54,28 | 54,38 | -1,55% | 2,30% | 6.182.886 |
| 23/07/2003 | 54,87 | 55,49 | 54,48 | 55,24 | +0,14% | 1,83% | 6.371.945 |
| 22/07/2003 | 56,77 | 56,87 | 54,63 | 55,16 | -3,36% | 3,95% | 12.449.821 |
| 21/07/2003 | 57,54 | 57,70 | 56,56 | 57,08 | -3,16% | 1,97% | 8.367.546 |
| 18/07/2003 | 58,59 | 58,97 | 57,83 | 58,94 | +1,25% | 1,94% | 4.883.890 |
| 17/07/2003 | 58,90 | 59,45 | 57,89 | 58,22 | -1,17% | 2,64% | 4.388.081 |
| 16/07/2003 | 59,16 | 59,45 | 58,57 | 58,90 | -0,23% | 1,48% | 4.836.625 |
| 15/07/2003 | 59,54 | 59,82 | 58,49 | 59,04 | +0,19% | 2,23% | 5.805.186 |
| 14/07/2003 | 58,73 | 59,77 | 58,61 | 58,92 | +0,50% | 1,98% | 5.649.454 |
| 11/07/2003 | 58,11 | 58,66 | 57,79 | 58,63 | +0,66% | 1,51% | 4.104.911 |
| 10/07/2003 | 58,64 | 58,81 | 57,82 | 58,24 | -0,55% | 1,68% | 4.679.634 |
| 09/07/2003 | 58,84 | 59,37 | 58,13 | 58,57 | -0,45% | 2,11% | 5.780.768 |
| 08/07/2003 | 58,92 | 59,24 | 58,59 | 58,84 | -0,37% | 1,10% | 4.325.410 |
| 07/07/2003 | 58,21 | 59,51 | 58,21 | 59,06 | +1,23% | 2,25% | 6.010.490 |
| 03/07/2003 | 58,40 | 58,83 | 57,78 | 58,34 | -0,94% | 1,80% | 4.933.355 |
| 02/07/2003 | 59,19 | 59,64 | 58,89 | 58,89 | +0,41% | 1,26% | 8.408.314 |
| 01/07/2003 | 57,73 | 58,79 | 56,98 | 58,65 | +1,52% | 3,14% | 6.840.506 |
| 30/06/2003 | 58,30 | 58,67 | 57,54 | 57,78 | -0,77% | 1,95% | 5.798.060 |
| 27/06/2003 | 58,09 | 59,24 | 57,84 | 58,23 | -1,58% | 2,40% | 5.028.618 |
| 26/06/2003 | 57,85 | 59,35 | 57,82 | 59,16 | +1,34% | 2,64% | 5.394.056 |